Drug Trial Radar · NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
7,000
Planned (sponsor's estimate)
Start
Aug 21, 2026
Primary completion
Oct 4, 2030
Study completion Oct 4, 2030
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.
Conditions
- Chronic Kidney Disease
Interventions
ElecoglipronDrug
Elicoglipron tablet
PlaceboDrug
Placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the effect of elecoglipron compared with placebo in reducing the risk of the composite of ≥ 50% sustained decline in eGFR, ESKD, or all-cause mortalityTime frame: Event-driven, trial is estimated to be up to 4.5 years
Locations
715 sites in 37 countries. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama · Not yet recruiting
Research Site
Montgomery, Alabama · Not yet recruiting
Research Site
Sheffield, Alabama · Not yet recruiting
Research Site
Peoria, Arizona · Not yet recruiting
Research Site
Phoenix, Arizona · Not yet recruiting
Research Site
Surprise, Arizona · Not yet recruiting
Research Site
Little Rock, Arkansas · Withdrawn
Research Site
Chula Vista, California · Not yet recruiting
Research Site
Concord, California · Not yet recruiting
Research Site
Daly City, California · Not yet recruiting
Research Site
Fremont, California · Not yet recruiting
Research Site
Huntington Beach, California · Not yet recruiting
Research Site
Huntington Park, California · Not yet recruiting
Research Site
Lomita, California · Not yet recruiting
Research Site
National City, California · Not yet recruiting
Research Site
Northridge, California · Not yet recruiting
Research Site
Northridge, California · Not yet recruiting
Research Site
Rolling Hills Estates, California · Withdrawn
Research Site
San Diego, California · Not yet recruiting
Research Site
San Francisco, California · Withdrawn
Research Site
San Mateo, California · Not yet recruiting
Research Site
Tarzana, California · Not yet recruiting
Research Site
Arvada, Colorado · Not yet recruiting
Research Site
Denver, Colorado · Not yet recruiting
Research Site
Hartford, Connecticut · Not yet recruiting
Research Site
Middlebury, Connecticut · Not yet recruiting
Research Site
Waterbury, Connecticut · Not yet recruiting
Research Site
Boca Raton, Florida · Not yet recruiting
Research Site
Boynton Beach, Florida · Not yet recruiting
Research Site
Cutler Bay, Florida · Not yet recruiting
Research Site
Fort Lauderdale, Florida · Not yet recruiting
Research Site
Hollywood, Florida · Not yet recruiting
Research Site
Jacksonville Beach, Florida · Not yet recruiting
Research Site
Jensen Beach, Florida · Not yet recruiting
Research Site
Lauderdale Lakes, Florida · Not yet recruiting
Research Site
Longwood, Florida · Not yet recruiting
Research Site
Melbourne, Florida · Not yet recruiting
Research Site
Miami, Florida · Not yet recruiting
Research Site
Miami, Florida · Not yet recruiting
Research Site
Ocoee, Florida · Not yet recruiting
Showing 40 of 715 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.